Implementation of PrEP Care Among Women in Family Planning Clinics

This study will evaluate implementation strategies to address barriers and increase uptake of PrEP among Black cisgender women in Planned Parenthood of Illinois (PPIL) health centers.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

PrEP Uptake HIV Prevention

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Eligible participants include ciswomen presenting at a PPIL health center with a positive STI test (syphilis, gonorrhea, or chlamydia) and identified in the EHR using STI testing records and new fields for optimizing support of provider PrEP counseling.

Exclusion criteria

Participants will be excluded if they are not PrEP eligible, have a negative STI test, or are not identified in the EHR.

Treatment and study plan

POWER Up strategies -

Behavioral

Clinics will implement adapted POWER Up intervention strategies when a patient is flagged as PrEP eligible.

Primary outcomes

PrEP prescriptions among Black women accessing PPIL services and eligible for PrEP.

Time frame: 1 month

PrEP eligibility among Black women will be defined based on positive STI test and identified in the EHR using STI testing records and new fields for optimizing support of provider PrEP counseling. Using de-identified patient-level EHR data for eligible women at each clinic within each time point, we will create a dichotomous variable for having received a prescription for PrEP during a given time period.

Secondary outcomes

Receipt of PrEP refills among Black women accessing FP services at 6 months.

Time frame: 6 months

Using de-identified patient-level EHR data for eligible patients at each clinic within each time point, we will create a dichotomous variable for receiving refills of prescriptions for PrEP of those with an initial PrEP prescription.

Study contacts

Contact information is provided by the study sponsor or research team.

Cristina MA Barkowski, MSW

CONTACT

[email protected]

312-942-6382

Kate P Palmer, MPH

CONTACT

[email protected]

312-563-9389

Sponsors and collaborators

Lead sponsor

Rush University Medical Center

Other

Collaborators

National Institute of Mental Health (NIMH)
Planned Parenthood of Illinois
University of Illinois at Chicago

Registry information

Important dates

Study start: 2026
Primary completion: 2027
Study completion: 2027
First posted: Mar 28, 2024
Registry last updated: Jan 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting